Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
The Journal of Pediatrics|December 8, 2004
Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional surveyJoachim Roesler, Mitchell E Horwitz, Capucine Picard, et al.
Frontiers in Immunology|November 21, 2018
Clinical T Cell Receptor Repertoire Deep Sequencing and Analysis: An Application to Monitor Immune Reconstitution Following Cord Blood TransplantationAthina Soragia Gkazi, Ben K Margetts, Teresa Attenborough, et al.
Frontiers in Immunology|July 24, 2019
Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working PartiesRaffaella Greco, Myriam Labopin, Manuela Badoglio, et al.
British Journal of Haematology|November 22, 2018
Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosisJuliana Montibeller Furtado-Silva, Annalisa Paviglianiti, Annalisa Ruggeri, et al.
Blood Advances|October 26, 2021
Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantationRachael Hough, Andre Lopes, Pip Patrick, et al.
Ejhaem|July 18, 2022
Immune reconstitution following umbilical cord blood transplantation: IRES, a study of UK paediatric patientsJohn Girdlestone, Meera Raymond, Bronwen Shaw, et al.
Lancet (London, England)|February 25, 2003
Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99Corinne Antoine, Susanna Müller, Andrew Cant, et al.
Blood Advances|January 4, 2018
Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantationMieke Aldenhoven, Brigitte T A van den Broek, Robert F Wynn, et al.
Clinical Pharmacokinetics|May 28, 2019
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve OutcomeRick Admiraal, Cornelia M Jol-van der Zijde, Juliana M Furtado Silva, et al.
Science Translational Medicine|August 26, 2011
Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correctionH Bobby Gaspar, Samantha Cooray, Kimberly C Gilmour, et al.
Pageof 16